Sbir phase II: a safe, fast, and cost-effective system for tissue removal in laparoscopic transabdominal hysterectomy and myomectomy
Active Cooperative Agreement Awarded Last action
- Award ID
- 2210308
- Recipient
-
Claria Medical, Inc. UEI KUGJGUJN2G75
- Awarding agency
-
National Science Foundation
- Obligated
- $2,000,000
Award facts
- Assistance listing
- 47.084 NSF Technology, Innovation, and Partnerships
- Completion date 88% complete
- Originally
- Funding
-
- $1,000,000.00 Federal
- $1,000,000.00 Non-federal
- Place of performance
- Mountain View, CA 94043, USA
Award details come from USAspending.gov.
Description
- Abstract
- The broader impact/commercial potential of this small business innovation research (sbir) phase II project is to make minimally invasive surgeries involving tissue removal safer, faster, simpler, and more cost-effective through the introduction of a novel tissue containment and removal system. The initial target market will focus on improving procedures for hysterectomy or uterus removal, usually because of enlargement due to uterine fibroids. Gynecologic surgeons perform approximately 500,000 hysterectomies per year in the united states and there is an urgent need for improved solutions for tissue removal. The proposed system: (1) lowers the risks of morbidity and mortality during minimally invasive surgery; (2) saves substantial time; and (3) enables conversion of open hysterectomies to minimally invasive with faster and safer tools, reducing healthcare costs by thousands of dollars per patient. This small business innovation research (sbir) phase II project aims to provide a hysterectomy and myomectomy tissue containment and surgical extraction system. This project has three main objectives: first, demonstrate that a novel laparoscopic system is an effective barrier in preventing potential upstaging of occult cancers, passes electrical safety testing, passes sterilization validation, and passes biocompatibility testing. Second, develop an appropriate training program for surgeon users. Third, demonstrate that the laparoscopic system is intuitive to use, safe, and effective. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $1,000,000 | $1,000,000 |
Quick answers
Who received award 2210308?
2210308 was awarded to Claria Medical, Inc. by National Science Foundation on June 15, 2022.
How much is award 2210308 worth?
$2,000,000 has been obligated on 2210308: $1,000,000 in federal funding and $1,000,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award